SCHEDULE: Tan Soo Seng Discloses 8.95% Stake in China SXT Pharma

Tan Soo Seng has reported beneficial ownership of 8.95% of China SXT Pharmaceuticals, Inc.'s ordinary shares and associated warrants.

Summary

• Tan Soo Seng reported beneficial ownership of 10,392,160 ordinary shares of China SXT Pharmaceuticals, Inc. as of July 29, 2025.
• This ownership represents 8.95% of the total outstanding ordinary shares and voting power of the Issuer.
• The percentage is calculated based on 116,027,758 Ordinary Shares outstanding as of July 29, 2025, comprising 116,027,226 Class A Ordinary Shares and 532 Class B Ordinary Shares.
• The total voting power of the Issuer is 116,053,826 votes, with Tan Soo Seng holding Class A Ordinary Shares.
• The securities were not acquired or held for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership, providing no inherent positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of a significant ownership stake in a publicly traded pharmaceutical company. It does not provide specific insights into broader industry trends or competitive landscape beyond the ownership structure of China SXT Pharmaceuticals, Inc.

Stakeholder Impact

• Shareholders: Disclosure of a significant 8.95% stake by an individual investor provides transparency regarding the company's ownership structure.

Key Dates

Keywords

China SXT Pharmaceuticals, Tan Soo Seng, Beneficial Ownership, SEC Filing, Schedule 13G, Ordinary Shares, Warrants, Shareholder Stake